TwinBeech Capital’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
TwinBeech Capital's TRVI Position: Q3 2026 in Review
TwinBeech Capital opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 10,000 shares worth $143K. The stake represents 0.03% of the portfolio and ranks #365 among its holdings.
222 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- TwinBeech Capital held 10,000 shares of Trevi Therapeutics worth $143K as of Q3 2026.
- Trevi Therapeutics was a new TwinBeech Capital position in Q3 2026.
- Trevi Therapeutics made up 0.03% of TwinBeech Capital's portfolio in Q3 2026, its #365 holding.
- 222 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.